Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2478711000168111 | Kaletra 133.3/33.3 capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 2478721000168116 | Kaletra 133.3/33.3 (lopinavir 133.3 mg + ritonavir 33.3 mg) capsule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Kaletra 133.3/33.3 (lopinavir 133.3 mg + ritonavir 33.3 mg) capsule (trade product unit of use) | has manufactured dose form | capsule | true | Inferred relationship | Some | ||
| Kaletra 133.3/33.3 (lopinavir 133.3 mg + ritonavir 33.3 mg) capsule (trade product unit of use) | has Australian BoSS | lopinavir | true | Inferred relationship | Some | 123919842 | |
| Kaletra 133.3/33.3 (lopinavir 133.3 mg + ritonavir 33.3 mg) capsule (trade product unit of use) | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Kaletra 133.3/33.3 (lopinavir 133.3 mg + ritonavir 33.3 mg) capsule (trade product unit of use) | Is a | Kaletra 133.3/33.3 | true | Inferred relationship | Some | ||
| Kaletra 133.3/33.3 (lopinavir 133.3 mg + ritonavir 33.3 mg) capsule (trade product unit of use) | Is a | lopinavir 133.3 mg + ritonavir 33.3 mg capsule | true | Inferred relationship | Some | ||
| Kaletra 133.3/33.3 (lopinavir 133.3 mg + ritonavir 33.3 mg) capsule (trade product unit of use) | has manufactured dose form | soft capsule | false | Inferred relationship | Some | ||
| Kaletra 133.3/33.3 (lopinavir 133.3 mg + ritonavir 33.3 mg) capsule (trade product unit of use) | has unit of use | capsule | true | Inferred relationship | Some | 1303826687 | |
| Kaletra 133.3/33.3 (lopinavir 133.3 mg + ritonavir 33.3 mg) capsule (trade product unit of use) | has intended active ingredient | lopinavir | true | Inferred relationship | Some | 123919842 | |
| Kaletra 133.3/33.3 (lopinavir 133.3 mg + ritonavir 33.3 mg) capsule (trade product unit of use) | has intended active ingredient | ritonavir | true | Inferred relationship | Some | 1303826686 | |
| Kaletra 133.3/33.3 (lopinavir 133.3 mg + ritonavir 33.3 mg) capsule (trade product unit of use) | has Australian BoSS | ritonavir | true | Inferred relationship | Some | 1303826686 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Kaletra 133.3/33.3 capsule, 90 | has TPUU | True | Kaletra 133.3/33.3 (lopinavir 133.3 mg + ritonavir 33.3 mg) capsule (trade product unit of use) | Inferred relationship | Some | 1 |
| Kaletra 133.3/33.3 capsule, 90, bottle | has TPUU | True | Kaletra 133.3/33.3 (lopinavir 133.3 mg + ritonavir 33.3 mg) capsule (trade product unit of use) | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR